Search results related to Brian F. Thomas

Showing results 1-25 of 148.

Synthesis and pharmacological evaluation of 1-phenyl-3-thiophenylurea derivatives as cannabinoid type-1 receptor allosteric modulators

November 2019

Comparison of cigarette, little cigar, and waterpipe tobacco smoke condensate and e-cigarette aerosol condensate in a self-administration model

October 2019

Route of administration effects on nicotine discrimination in female and male mice

August 2019

Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists

Current approaches for therapeutics development
July 2019

Do you feel it now?

Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice
July 2019

Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors

March 2019

Diarylureas containing 5-membered heterocycles as cb1 receptor allosteric modulators

Design, synthesis, and pharmacological evaluation
January 2019

Sex, THC, and hormones

Effects on density and sensitivity of CB1 cannabinoid receptors in rats
January 2019

Toxic by design?

Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures
January 2019

Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists

May 2018

Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-fluoro-CUMYL-PICA

May 2018

Detection of drugs and their metabolites in oral fluid

February 2018

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA (vol 35, pg 333, 2017)

January 2018

Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18

January 2018

Inhaled pharmaceutical product development perspectives

Challenges and opportunities
November 2017

Doping, performance-enhancing drugs, and hormones in sport

Mechanisms of action and methods of detection
November 2017

Labeling accuracy of cannabidiol extracts sold online

November 2017

The great divide

Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators
October 2017

Novel diarylurea based allosteric modulators of the cannabinoid CB1 receptor

Evaluation of importance of 6-pyrrolidinylpyridinyl substitution
September 2017

Identification of eight synthetic cannabinoids, including 5F-AKB48 in seized herbal products using DART-TOF-MS and LC-QTOF-MS as nontargeted screening methods

September 2017

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA

July 2017

Apparent CB1 receptor rimonabant affinity estimates

Combination with THC and synthetic cannabinoids in the mouse In vivo triad model
July 2017

Interactions of cannabinoids with biochemical substrates

May 2017

Allosteric modulation

An alternate approach targeting the cannabinoid CB1 receptor
May 2017

Vaping synthetic cannabinoids

A novel preclinical model of e-cigarette use in mice
April 2017

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!